nach oben

Erschienen in:

28.01.2020 | Original Paper

Medications for Opioid Use Disorder Utilization Among Oxford House Residents

Erschienen in: Community Mental Health Journal | Ausgabe 5/2020

Einloggen, um Zugang zu erhalten

Abstract

Medications for opioid use disorder (MOUD) and recovery homes that have traditionally served those not taking medications for their recovery are important resources for treating opioid use disorder. However, little is known whether such recovery homes are a good fit for persons utilizing MOUD, and whether residents’ characteristics such as drug histories and the composition of recovery homes in terms MOUD and non-MOUD residents are related to attitudes toward MOUD. The present investigation examined characteristics of persons utilizing MOUD, and attitudes regarding MOUD utilization among residents living in recovery homes (Oxford Houses, OH) in the U.S. consisting of MOUD and non-MOUD residents. Residents living with others who were utilizing MOUD reported more favorable attitudes than residents who were not living with such residents, but this was observed only among residents whose primary drug of choice involved heroin or opioids. There were no significant differences observed in terms of abstinence rates, involvement in 12-step groups, or previous MOUD treatments between residents utilizing or not utilizing MOUD. Findings suggest that persons utilizing MOUD benefit by recovery homes such as OHs whose residents have favorable attitudes toward MOUD, especially when living with fellow residents who utilize MOUD.

We used the term “using addict” in our survey because it is an idiom frequently used by Narcotics Anonymous (NA) members to represent one who is intentionally using substances for the purpose of altering one’s mood/mind. Although we respectfully acknowledge NA members’ use of and identification with the term “addict,” we do not condone the use of this term in the pejorative sense.

Collins, E. D., Horton, T., Reinke, K., Amass, L., & Nunes, E. V. (2007). Using buprenorphine to facilitate entry into residential therapeutic community rehabilitation. Journal of Substance Abuse Treatment,32, 167–175. https://doi.org/10.1016/j.sat.2006.03.018.CrossRefPubMed

Galanter, M. (2018). Combining medically assisted treatment and twelve-step programming: A perspective and review. American Journal of Drug and Alcohol Abuse,44, 151–159. https://doi.org/10.1080/00952990.2017.1306747.CrossRefPubMed

Galanter, M., Seppala, M., & Klein, A. (2016). Medication-assisted treatment for opioid dependence in twelve-step-oriented residential rehabilitation settings. Substance Abuse,37, 381–383. https://doi.org/10.1080/08897077.2016.1187241.CrossRefPubMed

Gallagher, J. R., Whitmore, T. D., Horsley, J., Marshall, B., Deranek, M., Callantine, S., et al. (2019). A perspective from the field: Five interventions to combat the opioid epidemic and ending the dichotomy of harm-reduction versus abstinence-based programs. Alcoholism Treatment Quarterly. https://doi.org/10.1080/07347324.2019.1571877.CrossRef

Hill, D. R., Conroy, S., Afzal, A., Lang, D., Steele, S., & Campbell, D. (2015). A comparison of methadone and buprenorphine-naloxone as opioid substitution therapy: The patient perspective in NHS Lanarkshire. Journal of Substance Use,20, 168–177. https://doi.org/10.3109/14659891.2014.894589.CrossRef

Humphreys, K., Kaskutas, L. A., & Weisner, C. (1998). The alcoholics anonymous affiliation scale: Development, reliability, and norms for diverse treated and untreated populations. Alcoholism: Clinical and Experimental Research,22, 974–978.CrossRef

Jason, L. A., Davis, M. I., Ferrari, J., & Anderson, E. (2007a). The need for substance abuse after-care: Longitudinal analysis of Oxford House. Addictive Behaviors,32, 803–818. https://doi.org/10.1016/j.addbeh.2006.06.014.CrossRefPubMed

Jason, L. A., Olson, B. D., Ferrari, J. R., Majer, J. M., Alvarez, J., & Stout, J. (2007b). An examination of main and interactive effects of substance abuse recovery on multiple indicators of adjustment. Addiction,102, 1114–1121. https://doi.org/10.1111/j.1360-0443.2007.01846.x.CrossRefPubMedPubMedCentral

Jason, L. A., Olson, B. D., & Foli, K. (2008). Rescued lives: The Oxford House approach to substance abuse. New York, NY: Routledge.

Kidorf, M., Brooner, R. K., Peirce, J., Gandotra, J., & Leoutsakos, J. (2018). Mobilizing community support in people receiving opioid-agonist treatment: A group approach. Journal of Substance Abuse Treatment,93, 1–6. https://doi.org/10.1016/j.sat.2018.07.004.CrossRefPubMedPubMedCentral

Litt, M. D., Kadden, R. M., Kabela-Cormier, E., & Petry, N. M. (2009). Changing network support for drinking: Network support project 2-year follow-up. Journal of Consulting and Clinical Psychology,77, 229–242. https://doi.org/10.1037/a0015252.CrossRefPubMedPubMedCentral

Majer, J. M., Droege, J. R., & Jason, L. A. (2010). A categorical assessment of twelve-step involvement in relation to recovery resources. Journal of Groups in Addiction & Recovery,5, 155–167. https://doi.org/10.1080/15560351003766158.CrossRef

Majer, J. M., Jason, L. A., Ferrari, J. R., & Miller, S. A. (2011). Twelve-step involvement among a U.S. national sample of Oxford House residents. Journal of Substance Abuse Treatment,41, 37–44. https://doi.org/10.1016/j.jsat.2011.01.010.CrossRefPubMedPubMedCentral

Majer, J. M., Droege, J. R., & Jason, L. A. (2012). Coping strategies in recovery: More evidence for categorical twelve-step involvement. Journal of Groups in Addiction & Recovery,7, 3–14. https://doi.org/10.1080/1556035X.2012.632317.CrossRef

Majer, J. M., Jason, L. A., Aase, D. M., Droege, J. R., & Ferrari, J. R. (2013). Categorical 12-step involvement and continuous abstinence at two-years. Journal of Substance Abuse Treatment,44, 46–51. https://doi.org/10.1016/j.jsat.2012.03.001.CrossRefPubMed

Majer, J. M., Beasley, C., Stecker, E., Bobak, T. J., Norris, J., Nguyen, H. Z., et al. (2018). Oxford house residents’ attitudes toward medication assisted treatment use in fellow residents. Community Mental Health Journal,54, 571–577. https://doi.org/10.1007/s10597-017-0218-4.CrossRefPubMed

Monico, L. B., Gryczynski, J., Mitchell, S. G., Schwartz, R. P., O’Grady, K. E., & Jaffe, J. H. (2015). Buprenorphine treatment and 12-Step meeting attendance: Conflicts, compatibilities, and patient outcomes. Journal of Substance Abuse Treatment,57, 89–95. https://doi.org/10.1016/j.jsat.2015.05.005.CrossRefPubMedPubMedCentral

Monico, L. B., Gryczynski, J., Schwartz, R. P., Jaffe, J. H., O’Grady, K. E., & Mitchell, S. G. (2018). Treatment outcomes among a cohort of African American buprenorphine patients: Follow-up at 12 months. The American Journal of Drug and Alcohol Abuse,44, 604–610. https://doi.org/10.1080/00952990.2018.1461877.CrossRefPubMedPubMedCentral

Narcotics Anonymous. (2016). Narcotics anonymous and persons receiving medication-assisted treatment. https://www.na.org/admin/include/spaw2/uploads/pdf/pr/2306_NA_PRMAT_1021.pdf

National Alliance for Recovery Residences (2019). Helping recovery residences adapt to support people with medication-assisted recovery. St. Paul; MN. Retrieved from: https://narronline.org/narr-releases-new-mat-guide-for-recovery-residence-operators/

Oxford House Inc. (2011). Oxford House Manual. MD: Silver Springs.

Schuman-Olivier, Z., Greene, M. C., Bergman, B. G., & Kelly, J. F. (2014). Is residential treatment effective for opioid use disorders? A longitudinal comparison of treatment outcomes among opioid dependent, opioid misusing, and non-opioid using emerging adults with substance use disorder. Drug and Alcohol Dependence,144, 178–185. https://doi.org/10.1016/j.drugalcdep.2014.09.00.CrossRefPubMedPubMedCentral

Schwartz, R. P., Kelly, S. M., O’Grady, K. E., Mitchell, S. G., Peterson, J. A., Reisinger, H. S., et al. (2008). Attitudes toward buprenorphine and methadone among opioid-dependent individuals. The American Journal on Addictions,17, 396–401. https://doi.org/10.1080/10550490802268835.CrossRefPubMedPubMedCentral

Stahler, G. J., Mennis, J., & DuCette, J. P. (2016). Residential and outpatient treatment completion for substance use disorders in the U.S.: Moderation analysis by demographics and drug of choice. Addictive Behaviors,58, 129–135. https://doi.org/10.1016/j.addbeh.2016.02.030.CrossRefPubMed

Stein, M. D., Anderson, B. J., & Bailey, G. L. (2015). Preferences for aftercare among persons seeking short-term opioid detoxification. Journal of Substance Abuse Treatment,59, 99–103. https://doi.org/10.1016/j.jsat.2015.07.002.CrossRefPubMedPubMedCentral

Substance Abuse and Mental Health Services Administration. (2011). SAMHSA’s National Registry of Evidence-Based Programs and Practices. Rockville, MD: Author. Retrieved from https://www.nrepp.samhsa.gov/ViewIntervention.aspx

Suzuki, J., & Dodds, T. (2016). Clinician recommendation of 12-step meeting attendance and discussion regarding disclosure of buprenorphine use among patients in office-based opioid treatment. Substance Abuse,37, 31–34. https://doi.org/10.1080/08897077.2015.1132292.CrossRefPubMed

Zywiak, W. H., Longabaugh, R., & Wirtz, P. W. (2002). Decomposing the relationships between pre-treatment social network characteristics and alcohol treatment outcome. Journal of Studies on Alcohol,63, 114–121.PubMed

Zywiak, W. H., Neighbors, C. J., Martin, R. A., Johnson, J. E., Eaton, C. A., & Rohsenow, D. J. (2009). The important people drug and alcohol interview: Psychometric properties, predictive validity, and implications for treatment. Journal of Substance Abuse Treatment,36, 321–330. https://doi.org/10.1016/j.jsat.2008.08.001.CrossRefPubMed

Titel: Medications for Opioid Use Disorder Utilization Among Oxford House Residents
Publikationsdatum: 28.01.2020
Erschienen in: Community Mental Health Journal / Ausgabe 5/2020
Print ISSN: 0010-3853
Elektronische ISSN: 1573-2789
DOI: https://doi.org/10.1007/s10597-020-00558-y

Neu im Fachgebiet Psychiatrie

23.04.2024 | Demenz | Nachrichten

Update Psychiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Medications for Opioid Use Disorder Utilization Among Oxford House Residents

Abstract

Neu im Fachgebiet Psychiatrie

Demenzkranke durch Antipsychotika vielfach gefährdet

Weniger postpartale Depressionen nach Esketamin-Einmalgabe

„Psychotherapie ist auch bei sehr alten Menschen hochwirksam!“

Auf diese Krankheiten bei Geflüchteten sollten Sie vorbereitet sein

Update Psychiatrie

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 5/2020

Methamphetamine Abuse Trends in Psychiatric Emergency Services: A Retrospective Analysis Using Big Data

Fresh Focus for Troubled Times

Attachment to Parents and Peers and Adolescent Mental Health: The Mediating Role of Alexithymia

Factors Affecting Happiness Among Rural Residents: A Cross Sectional Survey

Connecting Veterans and Their Community Through Narrative: Pilot Data on a Community Strengthening Intervention

Development of an After-School Day Treatment Program for Children with Severe Emotional/Behavioral Disturbances

Neu im Fachgebiet Psychiatrie

Demenzkranke durch Antipsychotika vielfach gefährdet

Weniger postpartale Depressionen nach Esketamin-Einmalgabe

„Psychotherapie ist auch bei sehr alten Menschen hochwirksam!“

Auf diese Krankheiten bei Geflüchteten sollten Sie vorbereitet sein

Update Psychiatrie